Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

SHA:688189 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	278.09	301.52	490.27	665.76	713.47	730.67
Cash & Short-Term Investments	278.09	301.52	490.27	665.76	713.47	730.67
Cash Growth	-49.47%	-38.50%	-26.36%	-6.69%	-2.35%	-24.04%
Accounts Receivable	29.66	42.51	199.9	563.74	741.49	590.81
Other Receivables	5.81	8.34	5.78	0.95	6.36	207.56
Receivables	35.47	50.85	205.68	564.69	747.85	798.37
Inventory	42.18	35.88	61.17	30.37	27.01	61.43
Prepaid Expenses	-	-	1.62	3.52	0.32	3.65
Other Current Assets	19.89	11.58	19.61	7.52	7.51	19.06
Total Current Assets	375.63	399.83	778.35	1,272	1,496	1,613
Property, Plant & Equipment	145.7	150.08	164.3	186.29	204.62	229.74
Goodwill	-	-	-	10.85	10.85	13.57
Other Intangible Assets	86.48	88.87	143.13	124.28	138.01	158.41
Long-Term Deferred Tax Assets	34.25	33.74	51.17	57.26	54.82	72.22
Long-Term Deferred Charges	126.11	118.42	77.5	64.19	46.23	40.48
Other Long-Term Assets	18.53	18.53	7.99	4.65	3.91	3.27
Total Assets	786.7	809.47	1,222	1,719	1,955	2,131

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	29.34	27.23	39.59	39.55	37.5	156.47
Accrued Expenses	7.78	26.22	53.39	31.97	39.26	56.34
Short-Term Debt	10	10.03	218.19	322.95	488.73	385.44
Current Portion of Long-Term Debt	-	-	-	-	50.85	33.9
Current Portion of Leases	-	-	0.71	0.71	0.68	1.13
Current Income Taxes Payable	1.36	0.57	0.57	1.2	2	-
Current Unearned Revenue	4.17	1.96	1.72	13.48	13.3	27.21
Other Current Liabilities	36.14	27.52	25.69	18.17	16.04	14.2
Total Current Liabilities	88.79	93.52	339.85	428.04	648.36	674.67
Long-Term Debt	-	-	-	-	-	50.85
Long-Term Leases	-	-	0.23	0.94	3.39	4.07
Long-Term Unearned Revenue	2.63	2.7	3	3.3	4.2	5.62
Long-Term Deferred Tax Liabilities	0.79	0.84	1.05	1.53	2.29	1.68
Total Liabilities	92.2	97.06	344.13	433.8	658.24	736.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	274.4	274.4	274.4	274.4	196	140
Additional Paid-In Capital	1,175	1,175	1,175	1,175	1,254	1,310
Retained Earnings	-653.37	-640.12	-503.22	-146.32	-135.45	-56.62
Treasury Stock	-29.25	-26.14	-10	-	-	-
Total Common Equity	767.2	783.55	936.59	1,303	1,314	1,393
Minority Interest	-72.7	-71.14	-58.29	-17.92	-17.99	0.79
Shareholders' Equity	694.5	712.41	878.31	1,286	1,296	1,394
Total Liabilities & Equity	786.7	809.47	1,222	1,719	1,955	2,131

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10	10.03	219.12	324.6	543.65	475.38
Net Cash (Debt)	268.09	291.49	271.15	341.16	169.82	255.29
Net Cash Growth	-18.90%	7.50%	-20.52%	100.89%	-33.48%	-58.59%
Net Cash Per Share	0.98	1.06	0.99	1.24	0.62	0.93
Filing Date Shares Outstanding	272.11	272.49	272.83	274.4	274.4	274.4
Total Common Shares Outstanding	272.11	272.49	272.83	274.4	274.4	274.4
Working Capital	286.85	306.31	438.5	843.82	847.82	938.51
Book Value Per Share	2.82	2.88	3.43	4.75	4.79	5.08
Tangible Book Value	680.72	694.68	793.46	1,168	1,166	1,221
Tangible Book Value Per Share	2.50	2.55	2.91	4.26	4.25	4.45
Buildings	-	220.68	220.56	220.56	220.27	220.27
Machinery	-	198.2	229.88	270.67	264.88	262.76
Construction In Progress	-	4.9	0.35	0.57	0.24	1.28

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error